Conjunctivitis screening: Difference between revisions
(Page Creation/Layout) |
m (Bot: Removing from Primary care) |
||
| (17 intermediate revisions by 4 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Conjunctivitis}} | {{Conjunctivitis}} | ||
{{CMG}} {{AE}} | {{CMG}} {{AE}} {{SaraM}} | ||
==Overview== | ==Overview== | ||
General [[screening]] for conjunctivitis is not recommended. However, according to the Centers for Disease Control and Prevention (CDC), screening for [[sexually transmitted diseases|sexually transmitted diseases (STDs)]] is recommended among pregnant women to [[prevent]] conjunctivitis and other medical conditions in [[newborns]].<ref name= Conjunctivitis-screening> Centers for Disease Control and Prevention (2015) http://www.cdc.gov/std/tg2015/screening-recommendations.htm Accessed on June 29, 2016</ref> | |||
==Screening== | ==Screening== | ||
General [[screening]] for conjunctivitis is not recommended. However, if a baby is born to a mother who has an [[sexually transmitted diseases|sexually transmitted disease (STD)]], during delivery the [[bacteria]] (''[[Chlamydia trachomatis]]'', ''[[Neisseria gonorrhoeae]]'') or [[virus]] (''[[Herpes simplex virus]]'') can pass from the [[birth canal]] into the baby's eyes, and cause septic conjunctivitis. Antibiotic ointment or eye drops is given to all babies immediately after birth to prevent conjunctivitis and other medical conditions in [[newborns]]. Occasionally, this treatment causes a mild chemical conjunctivitis, which is usually self-limiting. Screening has been recommended by CDC in pregnant women for sexually transmitted diseases (STDs) to prevent spreading the infection to the baby.<ref name= Conjunctivitis-screening > Centers for Disease Control and Prevention (2015) http://www.cdc.gov/std/tg2015/screening-recommendations.htm Accessed on June 29, 2016</ref><ref name=Screening-Chlamydia-Neisseria > Centers for Disease Control and Prevention (2002) http://www.cdc.gov/mmwr/PDF/rr/rr5115.pdf Accessed on June 29, 2016</ref> | |||
{| style="border: 0px; font-size: 90%; margin: 3px;" align=center | |||
|+ | |||
! style="background: #4479BA; width: 120px;" | {{fontcolor|#FFF|Organism}} | |||
! style="background: #4479BA; width: 550px;" | {{fontcolor|#FFF|Screening Recommendations in Pregnant Women}} | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC;" | '''''[[Chlamydia]]''''' | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*All pregnant women under 25 years of age | |||
*Pregnant women, aged 25 and older if at increased risk | |||
*Retest during the [[3rd trimester]] for women under 25 years of age or at risk | |||
*Pregnant women with chlamydial infection should have a test-of-cure 3-4 weeks after treatment and be retested within 3 months | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC;" | '''''[[Gonorrhea]]''''' | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*All pregnant women under 25 years of age and older women if at increased risk | |||
*Retest 3 months after treatment | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC;" | '''''[[Herpes simplex virus]]''''' | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*Evidence does not support routine HSV-2 serologic screening among asymptomatic pregnant women. However, type-specific serologic tests might be useful for identifying pregnant women at risk for HSV infection and guiding counseling regarding the risk for acquiring genital herpes during pregnancy | |||
|} | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
{{WS}} | |||
{{WH}} | |||
[[Category:Ophthalmology]] | [[Category:Ophthalmology]] | ||
[[Category: | [[Category:FinalQCRequired]] | ||
[[Category:Emergency medicine]] | |||
[[Category:Disease]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] | [[Category:Infectious disease]] | ||
Latest revision as of 21:07, 29 July 2020
|
Conjunctivitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Conjunctivitis screening On the Web |
|
American Roentgen Ray Society Images of Conjunctivitis screening |
|
Risk calculators and risk factors for Conjunctivitis screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [2]
Overview
General screening for conjunctivitis is not recommended. However, according to the Centers for Disease Control and Prevention (CDC), screening for sexually transmitted diseases (STDs) is recommended among pregnant women to prevent conjunctivitis and other medical conditions in newborns.[1]
Screening
General screening for conjunctivitis is not recommended. However, if a baby is born to a mother who has an sexually transmitted disease (STD), during delivery the bacteria (Chlamydia trachomatis, Neisseria gonorrhoeae) or virus (Herpes simplex virus) can pass from the birth canal into the baby's eyes, and cause septic conjunctivitis. Antibiotic ointment or eye drops is given to all babies immediately after birth to prevent conjunctivitis and other medical conditions in newborns. Occasionally, this treatment causes a mild chemical conjunctivitis, which is usually self-limiting. Screening has been recommended by CDC in pregnant women for sexually transmitted diseases (STDs) to prevent spreading the infection to the baby.[1][2]
| Organism | Screening Recommendations in Pregnant Women |
|---|---|
| Chlamydia |
|
| Gonorrhea |
|
| Herpes simplex virus |
|
References
- ↑ 1.0 1.1 Centers for Disease Control and Prevention (2015) http://www.cdc.gov/std/tg2015/screening-recommendations.htm Accessed on June 29, 2016
- ↑ Centers for Disease Control and Prevention (2002) http://www.cdc.gov/mmwr/PDF/rr/rr5115.pdf Accessed on June 29, 2016